Drug Channels

NOVEMBER 30, 2020

With drug pricing and benefit coverage top of mind for many Americans, coupled with a volatile election and overall healthcare landscape, the stakes are incredibly high for bio/pharma manufacturers. Staying on the pulse of industry trends, policies and changing regulations has never been more crucial.

Government 52

Government Pharma Companies Regulations Drugs 52

Drug Patent Watch

JANUARY 9, 2025

The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4].

Compliance 52

Compliance Drug Development Pharma Companies Therapies 52

Drug Target Review

MAY 23, 2023

The algae-derived non-digestible oligosaccharides can also influence the expression of cytokines that regulate the immune system. Exploring this unexploited resource through revived natural product research represents a new avenue for pharma companies to take on the challenges of IBD and other diseases.

Drugs 75

Drugs Small Molecule Production Disease 75

Metabolite Tales Blog

DECEMBER 19, 2023

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group A Metabolite Bioanalysis Working Group comprised of experts from 14 different pharma companies have proposed recommendations around best practice in metabolite bioanalysis during drug development.

Pharma Companies 52

Pharma Companies Drug Development Trials Compliance 52

H1 Blog

AUGUST 17, 2023

An HCP Digital Engagement Strategy Case Study In this case study , H1 partnered with a top global pharma company to enable them to expand their digital engagement strategies beyond traditional KOLs to deliver effective messaging related to patient care while also staying compliant with healthcare regulations – making it easier than ever before to keep (..)

Pharma Companies 52

Pharma Companies Regulations Treatment Research 52

H1 Blog

DECEMBER 11, 2024

In 2025, I predict that there will be global regulations requiring comprehensive diversity plans for all major markets, including the EU and EMEA. As these standards take shape, pharma companies will adopt tools and models to reach broader and more diverse participants.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

Advarra

JULY 19, 2022

The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval. The term drug substance and drug product are found in the NDA regulations 21 CFR 314.3,

Packaging 52

Packaging FDA Trials Regulations 52

The Pharma Data

DECEMBER 17, 2020

AB2 Bio – Swiss pharma company AB2 Bio Ltd. holding positions of increasing responsibility in Merck Research Laboratories before joining the company’s executive committee as CSO. Immune Regulation – U.K.-based based Immune Regulation Ltd. named Djordje Filipovic as its new chief commercial officer.

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

Altus Drug Development

JUNE 28, 2022

For instance, European pediatric regulation places certain requirements to support the safety and efficacy of drugs destined to be used on children ( source ). In an effort to reduce regulatory risk and reach the market faster, pharma companies might decide to pursue the approval of medicines with a simple lead formulation.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

NOVEMBER 5, 2020

The demand for an effective drug for nail fungus is high and MOB-015 can achieve a unique market position through its high antifungal effect,” says Anna Ljung, CEO of Moberg Pharma. The information was submitted for publication, through the agency of the contact persons set out above, at 8.00 CET on November 6, 2020.

Marketing 40

Marketing Production Regulations Pharma Companies 40

Drug Target Review

MAY 26, 2025

“Regulators are also much more interested in the manufacturing process, especially when it comes to stability.” Because analytical questions from both manufacturers and regulators are increasing, we have to think smarter with novel technologies. We can combine multiple biologically active molecules to create hybrid drugs.

Drug Development 52

Drug Development Drugs Therapies Pharmaceuticals 52

Codon

FEBRUARY 13, 2024

Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop.

Therapies 137

Therapies Virus DNA Clinical Trials 137

The Pharma Data

MAY 14, 2021

First, most are on the payroll of the big pharma companies earning lucrative commissions for pushing their drugs…. While most of the focus is on the pancreas, as that’s the organ that produces insulin and plays a major role in regulating erratic blood levels…. The second reason is even more common….

Doctors 52

Doctors Production Medical Schools Pharma Companies 52

The Anticancer Fund

JUNE 7, 2022

Also notable is that the majority of the new use patents are held by pharma companies, and that they maintain (pay to renew) their portfolio. Clinical investigation of this approach, particularly with respect to the sequencing of chemotherapy and immunotherapy, is warranted.

Drugs 40

Drugs Clinical Trials Trials Treatment 40

Agency IQ

JULY 12, 2024

BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products. The FDA is responsible for ensuring that medical products are adequately labeled in accordance with federal regulations, including the product’s “intended use” and relevant safety information.

FDA 40

FDA Regulations Production Science 40

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Carl was taking ibuprofen and opiates to manage the pain, but knew he had to be careful to regulate it because of the kidney and liver problems it could cause. It’s all about the bottom line, at any cost.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

Drug Target Review

MARCH 13, 2025

The journey from distrust to collaboration among industry, academia and regulators will expedite integration, minimise clinical failures and enhance economic sustainability. Techbio companies have initiated this approach. FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.

Drug Development 59

Drug Development Science Drugs Clinical Trials 59

The Pharma Data

DECEMBER 30, 2020

The reason for this is still not understood and many regulators may want it to be explained before authorizing it for broader use. One of the reasons they expect VC spending in biopharma to expand is that during 2020, particularly from March through about July, many pharma companies, if able, paused their clinical trials.

Vaccine 52

Vaccine FDA Trials Therapies 52

The Pharma Data

DECEMBER 16, 2020

Recombinant monoclonal antibodies are designed to enhance the immune system’s ability to regulate cell functions. and will leverage a major COVID-19 vaccine partnership the company struck with the U.K. Defense Advanced Research Projects Agency (DARPA), as well as previous funding from the Bill and Melinda Gates Foundation.

Vaccine 52

Vaccine DNA Government Pharma Companies 52

Drug & Device Law

APRIL 7, 2023

The company lodged a request under the Freedom of Information Act (“FOIA”), which the FDA refused. So the company sued, and the district judge ruled that the FDA had no valid basis to withhold the requested information. The company therefore submitted a supplemental New Drug Application, or sNDA, seeking approval for that use.

FDA 64

FDA Government Pharma Companies Regulations 64